[go: up one dir, main page]

CL2007003841A1 - COMPOUNDS DERIVED FROM 4 (5H-1 LAMBDA-TIAZOL-2-IL) PIPERIDINE; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT DIABETES. - Google Patents

COMPOUNDS DERIVED FROM 4 (5H-1 LAMBDA-TIAZOL-2-IL) PIPERIDINE; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT DIABETES.

Info

Publication number
CL2007003841A1
CL2007003841A1 CL2007003841A CL2007003841A CL2007003841A1 CL 2007003841 A1 CL2007003841 A1 CL 2007003841A1 CL 2007003841 A CL2007003841 A CL 2007003841A CL 2007003841 A CL2007003841 A CL 2007003841A CL 2007003841 A1 CL2007003841 A1 CL 2007003841A1
Authority
CL
Chile
Prior art keywords
compounds
tiazol
lambda
piperidine
pharmaceutical composition
Prior art date
Application number
CL2007003841A
Other languages
Spanish (es)
Inventor
Xin Cheng Peng Clemens Ed Chen
Original Assignee
Metabolex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40261614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003841(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Metabolex Inc filed Critical Metabolex Inc
Publication of CL2007003841A1 publication Critical patent/CL2007003841A1/en

Links

CL2007003841A 2006-12-28 2007-12-27 COMPOUNDS DERIVED FROM 4 (5H-1 LAMBDA-TIAZOL-2-IL) PIPERIDINE; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT DIABETES. CL2007003841A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87790306P 2006-12-28 2006-12-28

Publications (1)

Publication Number Publication Date
CL2007003841A1 true CL2007003841A1 (en) 2008-03-14

Family

ID=40261614

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2007003841A CL2007003841A1 (en) 2006-12-28 2007-12-27 COMPOUNDS DERIVED FROM 4 (5H-1 LAMBDA-TIAZOL-2-IL) PIPERIDINE; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT DIABETES.

Country Status (5)

Country Link
CN (1) CN101616586B (en)
AR (1) AR064702A1 (en)
CL (1) CL2007003841A1 (en)
TW (1) TWI414523B (en)
ZA (1) ZA200904281B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
PL2280704T3 (en) * 2008-03-31 2015-10-30 Cymabay Therapeutics Inc Oxymethylene aryl compounds and uses thereof
EP2483281B1 (en) 2009-10-01 2014-06-04 Cymabay Therapeutics, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
JP5960683B2 (en) * 2010-04-28 2016-08-02 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ Ketoheteroarylpiperidine and -piperazine derivatives as fungicides
CA2802541A1 (en) * 2010-06-23 2011-12-29 Metabolex, Inc. Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
CN103467398B (en) * 2013-09-03 2015-01-21 浙江医药高等专科学校 Triazole amide compounds, and preparation method and application thereof in resisting diabetes
CN105960405B (en) * 2014-01-06 2021-02-19 理森制药股份公司 Glutaminase inhibitors
WO2018026890A1 (en) 2016-08-03 2018-02-08 Cymabay Therapeutics Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CN111072652B (en) * 2018-10-19 2023-05-23 暨南大学 Compounds for the treatment of diabetes and/or related disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1829718A (en) * 2003-07-14 2006-09-06 艾尼纳制药公司 Fused aryl and heteroaryl derivatives as metabolism modulators and prevention and treatment of disorders associated therewith
WO2005061489A1 (en) * 2003-12-24 2005-07-07 Prosidion Limited Heterocyclic derivatives as gpcr receptor agonists

Also Published As

Publication number Publication date
TWI414523B (en) 2013-11-11
CN101616586B (en) 2014-08-13
CN101616586A (en) 2009-12-30
ZA200904281B (en) 2010-08-25
AR064702A1 (en) 2009-04-22
TW200833688A (en) 2008-08-16

Similar Documents

Publication Publication Date Title
CL2007003841A1 (en) COMPOUNDS DERIVED FROM 4 (5H-1 LAMBDA-TIAZOL-2-IL) PIPERIDINE; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT DIABETES.
BRPI0809977A2 (en) USE OF A COMPOUND, COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING
CL2008000703A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT HEMATOLOGICAL DISORDERS.
CL2008000369A1 (en) COMPOUNDS DERIVED FROM PYRIDOPIRIMIDINONES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT PAIN, DEPRESSION, CARDIOVASCULAR DISEASES, RESPIRATORY DISEASES AND PSYCHIATRIC DISEASES.
CL2007001325A1 (en) COMPOUNDS DERIVED FROM BICYCLES, CEPT INHIBITORS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT HYPERLIPIDEMIA, ARTERIOESCLEROSIS, AMONG OTHER ILLNESSES.
BRPI0815079A2 (en) 1,2-DIAMIDE-ETHYLENE DERICTED COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THIS COMPOUND
BRPI0814593A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
CL2008002041A1 (en) Piperidine derived compounds; pharmaceutical composition comprising said compounds; and its use to treat anxiety.
CL2007003061A1 (en) COMPOUNDS DERIVED FROM 3,5-DIOXI-BENZAMIDA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT A MEDIUM DISEASE THROUGH GLK, SUCH AS TYPE 2 DIABETES.
CL2007003470A1 (en) UREA DERIVATIVE COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE AS ANTIBACTERIALS.
CL2007003176A1 (en) COMPOUNDS DERIVED FROM NICOTINAMIDE, INHIBITORS OF 11BETAHSD1; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT METABOLIC SYNDROME, TYPE 2 DIABETES, OBESITY OR ATEROSCLEROSIS.
CL2008000197A1 (en) COMPOUNDS DERIVED FROM 2,4-DIAMINO PIRIMIDINA, ANTRANILAMIDE INHIBITORS OF CINASA AURORA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT CANCER.
CL2008000316A1 (en) COMPOUNDS DERIVED FROM 2-METILSULFONIL-1,2,3,4-TETRAHYDROISOQUINOLINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT DIABETES, HYPERLIPIDEMIA, CARDIAC DISEASES, ARTHRITIS, OSTEOPOROSIS, HYPERTENSION, CATARA
BRPI0815170A2 (en) Pharmaceutical composition comprising an sglt 2 inhibitor
CL2007002916A1 (en) COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS.
CL2007002446A1 (en) COMPOUNDS DERIVED FROM MORFOLINO PIRIMIDINA; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO PRODUCE AN ANTIPROLIFERING EFFECT.
CL2007003232A1 (en) COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS.
CL2007003565A1 (en) COMPOUNDS DERIVED FROM REPLACED PIPERIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT AN HIV INFECTION.
CL2007003226A1 (en) COMPOUNDS DERIVED FROM PIRIDINONA; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT CANCER.
BRPI0816553A2 (en) "compound, pharmaceutical composition, use of a composition, use of a compound, and process for the preparation of a compound"
BRPI0716495A2 (en) (R, R) - PHENOTEROL AND (R, R) - OR (R, S) - PHENOTEROL ANALOGUE, USE OF THE SAME IN THE PREPARATION OF PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION UNDERSTANDING SUCH COMPOUNDS.
CL2007001759A1 (en) METFORMIN COMPOUND R - (+) LIPOATE; MIXTING THAT METFORMIN AND ACID R - (+) LIPOIC; PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMPOUND; METHOD FOR PREPARING THE COMPOUND; KIT; AND USE TO TREAT DIABETES.
CL2007003614A1 (en) COMPOUNDS DERIVED FROM SULFONIL-FENIL-2H- [1,2,4] OXADIAZOL-5-ONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; PREPARATION PROCEDURE; AND USE OF THE COMPOUND IN THE TREATMENT OF METABOLISM DISORDERS, AS DIABETES MELLITUS, DIS
BRPI0809667A2 (en) COMPOUND, MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND
CL2007002377A1 (en) COMPOUNDS DERIVED FROM QUINAZOLINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE AS ANTICANCERIGENO.